| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0206 |
| Document Type: 3/A |
| Period of Report: 12/19/19 |
| Date of Original Submission: 1/6/20 |
| No Securities Owned: 0 |
| Issuer: |
| Issuer CIK: 1553643 |
| Issuer Name: RELMADA THERAPEUTICS, INC. |
| Issuer Trading Symbol: RLMD |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1644079 |
| | Owner Name: GLASSPOOL JOHN |
| Reporting Owner Address: |
| | Owner Street 1: C/O RELMADA THERAPEUTICS, INC. |
| | Owner Street 2: 880 THIRD AVENUE, 12TH FLOOR |
| | Owner City: NEW YORK |
| | Owner State: NY |
| | Owner ZIP Code: 10022 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? No |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: |
| | Other Text: |
| Derivative Table: |
| Derivative Holding: |
| | Security Title: |
| | | Value: Options to purchase common stock |
| | Conversion or Exercise Price: |
| | | Value: 43.47 |
| | Exercise Date: |
| | | Value: 12/19/19 |
| | | Footnote ID: F1 |
| | Expiration Date: |
| | | Value: 12/19/29 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 200,000 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: Options granted on December 19, 2019 to purchase an aggregate of 200,000 shares of common stock. A total of 25% of the options will vest one year from the grant date, and the remaining 75% shall vest in equal quarterly increments of 6.25% of the initial option grant over the following three year period. |
| Remarks: Form 3 amended because inadvertently reported ownership of common stock in form filed on January 6, 2010. |
| Owner Signature: |
| Signature Name: /s/ John Glasspool |
| Signature Date: 1/7/20 |
